Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

Design of ADAPT FORWARD, a Phase 2a Study to Evaluate the Safety, Efficacy, and Tolerability of Intravenous Empasiprubart as an Add-on Therapy to Intravenous Efgartigimod in Adult Participants with Generalized Myasthenia Gravis